Article info
PDFColorectal cancer
Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease
- Correspondence to:
Dr J Sträter
Department of Pathology, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany; joern.straetermedizin.uni-ulm.de
Citation
Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease
Publication history
- Accepted November 9, 2004
- Revised October 27, 2004
- First published April 14, 2005.
Online issue publication
April 14, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Gut